Home › Trial NCT01643668
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
- Trial IDNCT01643668
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorMassachusetts General Hospital
- Enrollment34
- Start date2012-07
- ConditionsAcute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndrome
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.